foxo4-dri peptide human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI 10mg | PeptideX Research
FOXO4 DRI 10mg PeptideX Research FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PMC Buy FOXO4 DRI Peptide Vial UK PharmaLabGlobal Buy FOXO4 DRI Exceptional 99%+ Purity Third Party COA Included FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





